Poster Presentation
Paromita Majumder
Senior Field Application Scientist
Sphere Bio
Abstract
Antibody drug development is costly and complex. Sphere Bio’s next-gen Cyto-Mine® Chroma system accelerates Antibody Discovery using picodroplet technology and multi-laser single-cell analysis. It enables rapid functional assessment of viability, productivity, and fluorescence followed by sorting and isolation of high value cells.
Cyto-Mine® Chroma’s high-throughput screening of millions of single cells per day streamlines screening and significantly accelerates therapeutic development.
We are excited to be part of the 13th Antibody Industrial Symposium 2025 (AIS 2025), taking place on June 25-26, 2025 at the Palais des Congrès de Tours in Tours, France. This prestigious international symposium, organized by LabEx MAbImprove and MabDesign, will bring together experts in the field of therapeutic antibodies, recombinant proteins, and biomedicines.
Sphere Bio is thrilled to showcase our high-throughput screening and functional genomics technologies designed to accelerate therapeutic discovery. Don’t miss the chance to connect with industry leaders and researchers – register today and join us in Tours!
